[Standardized evaluation of red, green and blue perception. Comparison between color arrangement and computer-assisted test procedures]

BACKGROUND

Computerized colortests offer the possibility of determining quantitative color contrast thresholds under standardized conditions. Arrangement tests allow semi-quantitative evaluation of the red, green and blue color sense. To validate the results of a new computerized test, its results are compared to those of arrangement tests.

PATIENTS AND METHODS

Thirty-five patients with retinitis pigmentosa (RP, mean age 38.51, +/- 15.14) as well as 30 normal observers (mean age 36.52, +/- 14.33) were evaluated. The computerized color test COLDEF was used, which is a calibrated screen that presents color optotypes on a colored background. All colors are chosen from three-color confusion axes of the CIE-Lu'v' color chart (protan, deutan and tritan axis). By a staircase procedure, the colors of the optotype and background were varied until the observers minimal color contrast threshold is detected. To compare the results of COLDEF with a routine diagnostic tool, the Farnsworth panel D-15 and Lanthony désaturé test were chosen. The results of the arrangement tests were scored by a categorization scheme.

RESULTS

Normal observers showed no elevated thresholds either in COLDEF nor in the panel tests. In the RP group increased thresholds along the blue confusion axis could be detected in most cases. Furthermore, COLDEF showed increased thresholds along the red and green axes in some patients. With the computerized test it is always possible to identify the color axis concerned. The new test allows a fast and quantitative assessment of acquired color vision deficiencies.

Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations

Maternal medication during the first trimester of pregnancy has been discussed as a risk factor for development of birth defects. The correlation between maternal drug use and major malformations was investigated in a population-based case-control study in Mainz. Over a period of 5 years (1990-1994), 20,248 livebirths, stillbirths, and abortions underwent physical and sonographic examination, and anamnestic data were collected. A total of 1,472 births with congenital anomalies (cases) and 9,682 births without major and minor malformations (controls) were analyzed. We distinguished between 30 different drug categories, which were divided into medication taken continuously (before and during pregnancy; CM) and acute medication (drugs given within the first 3 months of gravidity; AM). Statistically highly-significant results [CM: Odds Ratios (OR) 1.2, Confidence Intervals (CI) 1.1-1.4, P = 0.008; AM: OR 1.2, CI 1.1-1.3, P = 0.008] were established for maternal drug use in correlation to birth defects. For the majority of combinations between drugs and specific malformations no teratogenic risks were found. However, statistically significant associations were recorded for antiallergics and heart anomalies (CM, AM) as well as musculoskeletal anomalies (AM); for bronchodilators and heart anomalies (CM, AM); for antiepileptics and anomalies of the internal urogenital system (CM), as well as cleft palate/cleft lips (AM); for thyroid hormones and anomalies of the nervous system (CM, AM), as well as anomalies of the external urogenital system (CM, AM); for insulin and anomalies of the musculoskeletal system (CM); for digitalis and anomalies of the musculoskeletal system (AM).